The clinical efficacy of poly(ethylene glycol)-modified proteins
- 1 January 1990
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 11 (1-3), 139-148
- https://doi.org/10.1016/0168-3659(90)90127-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.Circulation Research, 1988
- Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminaseThe Journal of Pediatrics, 1988
- The role of superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in ratsClinical Science, 1987
- Increased survival of skin flaps by scavengers of superoxide radicalThe FASEB Journal, 1987
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987
- Safety evaluation of free radical scavengers peg-catalase and peg-superoxide dismutaseJournal of Free Radicals in Biology & Medicine, 1986
- Influence of antioxidant enzymes in reduction of optic disc edema in experimental optic neuritisJournal of Free Radicals in Biology & Medicine, 1986
- Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalaseJournal of Free Radicals in Biology & Medicine, 1986
- Oxygen Radical Dependent Lung Damage following Thermal Injury of Rat SkinPublished by Wolters Kluwer Health ,1983
- HYPOURICAEMIC EFFECT OF POLYETHYLENEGLYCOL MODIFIED URATE OXIDASEThe Lancet, 1981